Valentin Busch
Elastrin develops new approach against “Inflammatory Storm” that kills most Corona patients
A new approach to preventing the most severe outcomes of lung diseases, including COVID-19, has been developed by Elastrin Therapeutics Inc.
top of page
At Elastrin, there‘s something new every day.
Elastin Fiber antibodies guide the therapy to where it needs to be
Search
Valentin Busch
Mar 3, 20191 min read
Researchers Reverse Vascular Calcification in Chronic Kidney Disease Animal Model
Clemson University researchers published pre-clinical proof of reversing in lab animals the leading cause of cardiovascular events in...
Valentin Busch
Jan 12, 20191 min read
CSO Naren Vyavahare receives USD 2.2 million from NIH for nanoparticle research
Elastrin's Chief Scientific Officer Prof. Naren Vyavahare was granted USD 2.2 million from the National Institutes of Health to advance...
Valentin Busch
Nov 16, 20181 min read
Elastrin Therapeutics receives $25.000 grant by SCRA and is admitted to SC Launch program
The South Carolina Research Authority (SCRA) has granted Elastrin $25.000 in financial support through its Academic Start-up Assistance...
Valentin Busch
Oct 2, 20181 min read
Elastrin wins Entrepreuner award!
Elastrin Therpapeutics has won the 2018 Xi´an International Entrepreneuship Competition held in Hamburg October 19, 2018 and was selected...
bottom of page